BioNTech (NASDAQ:BNTX) Shares Down 6.4% Following Analyst Downgrade
BioNTech SE (NASDAQ:BNTX – Get Free Report) was down 6.4% during mid-day trading on Tuesday after Morgan Stanley lowered their price target on the stock from $145.00 to $139.00. Morgan Stanley currently has an overweight rating on the stock. BioNTech traded as low as $98.25 and last traded at $98.61. Approximately 739,834 shares traded hands […]
BioNTech SE (NASDAQ:BNTX – Get Free Report) was down 6.4% during mid-day trading on Tuesday after Morgan Stanley lowered their price target on the stock from $145.00 to $139.00. Morgan Stanley currently has an overweight rating on the stock. BioNTech traded as low as $98.25 and last traded at $98.61. Approximately 739,834 shares traded hands […]
